Quantitative proteomics in laser capture microdissected sleep nuclei from rat brain.

Area of Science:

• Neuroproteomics
• Pharmacology
• Mass Spectrometry

Background:

• The ventral tegmental area (VTA) is crucial for reward and motivation.
• Understanding VTA proteome changes is vital for neurological research.
• Pharmacological interventions can significantly impact brain protein expression.

Purpose of the Study:

• To quantify proteome alterations in the rat VTA following orexin system modulation.
• To apply stable isotope labeling of amino acids in mammals (SILAM) coupled with laser capture microdissection (LCM) for precise proteomic analysis.
• To identify specific proteins affected by orexin peptide (Ox-B) and orexin receptor antagonist (ORA) administration.

Main Methods:

• In vivo stable isotope labeling using (13)C6(15)N2-lysine in rats.
• Laser capture microdissection (LCM) to isolate the VTA.
• Quantitative proteomic analysis using mass spectrometry to compare labeled and unlabeled samples.
• Administration of Ox-B, ORA, or a combination thereof.

Main Results:

• Differential protein quantitation revealed significant changes in VTA proteome.
• ORA administration led to decreased abundance of five proteins, including alpha-synuclein and rat myelin basic protein.
• ORA treatment resulted in increased abundance of six proteins, such as 2',3'-cyclic nucleotide 3'-phosphophosphodiesterase.

Conclusions:

• The SILAM-LCM approach successfully identified proteomic changes in the rat VTA.
• Orexin receptor antagonism significantly impacts the expression of specific VTA proteins.
• These findings provide insights into the neurobiological mechanisms of orexin signaling.